by
Lauren Dubinsky, Senior Reporter | February 02, 2015
A new MarketsandMarkets report predicts the global pre-clinical imaging market is "expected to reach" $797 million by 2019, at a CAGR of 6.0 percent from 2014 to 2019.
The report broke down the global pre-clinical imaging market into seven segments: optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems.
Key factors impacting the market included technological advancements in molecular imaging, rising adoption of multi-modality imaging systems in pre-clinical research studies, and the increased acceptance of pre-clinical imaging in drug discovery and development, the report found.
Ad Statistics
Times Displayed: 19605
Times Visited: 366 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
This greater demand was offset by declining NIH budgets for medical science research studies, and high implementation cost of sophisticated pre-clinical imaging systems, the report also advised.
As of 2014, North America holds the largest share of the global pre-clinical imaging market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2 percent from 2014 to 2019.
